Page last updated: 2024-10-22

dan 2163 and Ventricular Fibrillation

dan 2163 has been researched along with Ventricular Fibrillation in 1 studies

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research Excerpts

ExcerptRelevanceReference
"As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US FDA Adverse Event Reporting System (FAERS) database to detect signals of torsadogenicity for antipsychotics (APs)."1.39Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. ( Behr, ER; De Ponti, F; Koci, A; Moretti, U; Poluzzi, E; Raschi, E; Spina, E; Sturkenboom, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poluzzi, E1
Raschi, E1
Koci, A1
Moretti, U1
Spina, E1
Behr, ER1
Sturkenboom, M1
De Ponti, F1

Other Studies

1 other study available for dan 2163 and Ventricular Fibrillation

ArticleYear
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.
    Drug safety, 2013, Volume: 36, Issue:6

    Topics: Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Be

2013